We are live on !
Find out more
Davidson & Garrard Portfolio holdings
AUM
$425M
Turnover
4.35%
1-Year Est. Return
14.62%
This Fund
S&P 500
This Quarter Est. Return
+2.93%
1 Year Est. Return
+14.62%
3 Year Est. Return
+25.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$403M
AUM Growth
-$3.27M
(-0.81%)
Cap. Flow
-$11.4M
Cap. Flow % of AUM
Cap. Flow %
-2.82%
Top 10 Holdings %
Top 10 Hldgs %
23.47%
Holding
196
New
7
Increased
55
Reduced
88
Closed
16
Avg Time Held
2.5
years
Top 10 Avg Time Held
2.6
years
Top 20 Avg Time Held
2.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hanesbrands
HBI
|
+$1.56M |
| 2 |
Starbucks
SBUX
|
+$1.07M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$724K |
| 4 |
Vanguard High Dividend Yield ETF
VYM
|
+$551K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$502K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$3.09M |
| 2 |
DNY
DONNELLEY R R & SONS CO
DNY
|
+$1.82M |
| 3 |
State Street SPDR S&P International Small Cap ETF
GWX
|
+$902K |
| 4 |
DaVita
DVA
|
+$805K |
| 5 |
Emerson Electric
EMR
|
+$747K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 19.36% |
| 2 | Healthcare | 16.67% |
| 3 | Technology | 13.78% |
| 4 | Financials | 10% |
| 5 | Communication Services | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.07T
| $14.9M | 3.69% |
525,976
-4,668
| -0.9% | -$124K |
2013 Q2
13 quarters
|
|
2
iShares Preferred and Income Securities ETF
PFF
$11.9B
| $10.2M | 2.54% |
258,871
+8,346
| +3% | +$333K |
2013 Q2
13 quarters
|
|
3
Verizon
VZ
$186B
| $9.6M | 2.38% |
184,677
+77
| +0% | +$4.13K |
2013 Q2
13 quarters
|
|
4
GE Aerospace
GE
$296B
| $9.6M | 2.37% |
67,369
-635
| -0.9% | -$94.7K |
2013 Q2
13 quarters
|
|
5
Thermo Fisher Scientific
TMO
$249B
| $9.5M | 2.37% |
59,972
-1,375
| -2% | -$212K |
2013 Q2
13 quarters
|
|
6
AT&T
T
$141B
| $8.9M | 2.21% |
290,164
+9,484
| +3% | +$300K |
2013 Q2
13 quarters
|
|
7
CVS Health
CVS
$120B
| $8.88M | 2.21% |
99,801
+496
| +0.5% | +$46.8K |
2013 Q2
13 quarters
|
|
8
Becton Dickinson
BDX
$54.2B
| $7.91M | 1.96% |
45,114
-2,058
| -4% | -$352K |
2013 Q2
13 quarters
|
|
9
ExxonMobil
XOM
$753B
| $7.72M | 1.92% |
88,483
-6,618
| -7% | -$587K |
2013 Q2
13 quarters
|
|
10
PepsiCo
PEP
$185B
| $7.33M | 1.82% |
67,358
-1,672
| -2% | -$180K |
2013 Q2
13 quarters
|
|
11
DELISTED
Spectra Energy Corp Wi
SE
| $7.16M | 1.78% |
167,471
-3,609
| -2% | -$137K |
2013 Q2
13 quarters
|
|
12
AbbVie
ABBV
$505B
| $7.12M | 1.77% |
112,944
+630
| +0.6% | +$40.8K |
2013 Q2
13 quarters
|
|
13
JPMorgan Chase
JPM
$881B
| $6.8M | 1.69% |
102,111
-2,786
| -3% | -$182K |
2013 Q2
13 quarters
|
|
14
Microchip Technology
MCHP
$40.2B
| $6.73M | 1.67% |
216,502
-1,920
| -0.9% | -$55.8K |
2013 Q2
13 quarters
|
|
15
Procter & Gamble
PG
$374B
| $6.4M | 1.59% |
71,323
-3,494
| -5% | -$303K |
2013 Q2
13 quarters
|
|
16
Microsoft
MSFT
$3.89T
| $6.34M | 1.58% |
110,137
-9,199
| -8% | -$519K |
2013 Q2
13 quarters
|
|
17
Intel
INTC
$460B
| $6.22M | 1.54% |
164,640
-4,274
| -3% | -$151K |
2013 Q2
13 quarters
|
|
18
iShares Core S&P 500 ETF
IVV
$876B
| $5.97M | 1.48% |
27,435
+2,020
| +8% | +$439K |
2013 Q2
13 quarters
|
|
19
Bank of America
BAC
$354B
| $5.9M | 1.47% |
377,103
+7,737
| +2% | +$115K |
2013 Q2
13 quarters
|
|
20
Pfizer
PFE
$171B
| $5.82M | 1.44% |
181,027
+9,198
| +5% | +$308K |
2013 Q2
13 quarters
|
|
21
Merck
MRK
$358B
| $5.66M | 1.4% |
94,991
-1,557
| -2% | -$91K |
2013 Q2
13 quarters
|
|
|
22
Vanguard Dividend Appreciation ETF
VIG
$114B
| $5.56M | 1.38% |
66,266
+8,537
| +15% | +$724K |
2013 Q2
13 quarters
|
|
23
Meta Platforms (Facebook)
META
$1.64T
| $5.49M | 1.36% |
42,831
-225
| -0.5% | -$27.9K |
2013 Q2
13 quarters
|
|
24
Johnson & Johnson
JNJ
$635B
| $5.4M | 1.34% |
45,745
-4,040
| -8% | -$490K |
2013 Q2
13 quarters
|
|
25
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $5.36M | 1.33% |
173,350
+1,465
| +0.9% | +$45.3K |
2013 Q2
13 quarters
|
|
Similar funds
SD
MCL
GIIO
JPCCM
Davidson & Garrard's Q3 2016 Portfolio in Review
As of Q3 2016, Davidson & Garrard held 196 positions worth $403M, down 0.81% from $406M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Davidson & Garrard's Q3 2016 filing shows 7 new, 55 increased, 88 reduced and 16 closed positions. Its largest new stake was Hanesbrands: 59,186 shares worth $1.49M. The largest sale was Xtrackers MSCI EAFE Hedged Equity ETF, an estimated $3.09M.
By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
- Davidson & Garrard's largest Q3 2016 buy was Hanesbrands: 59,186 shares worth $1.49M.
- Davidson & Garrard added most to Starbucks in Q3 2016, an estimated $1.07M increase.
- Davidson & Garrard's biggest Q3 2016 reduction was Xtrackers MSCI EAFE Hedged Equity ETF, cutting an estimated $3.09M.
- Davidson & Garrard fully exited DONNELLEY R R & SONS CO in Q3 2016, selling an estimated $1.82M.
- Davidson & Garrard's ten largest holdings make up 23% of its $403M portfolio in Q3 2016.
- Davidson & Garrard opened 7 new positions and closed 16 in Q3 2016.
- Davidson & Garrard's portfolio value fell 0.81% quarter-over-quarter to $403M.
Based on Davidson & Garrard's 13F filing for Q3 2016, filed 8 Nov 2016.